Coffee consumption and NAFLD: a community based study on 1223 subjects
- PMID: 26530296
- PMCID: PMC4632464
- DOI: 10.1186/s13104-015-1645-3
Coffee consumption and NAFLD: a community based study on 1223 subjects
Abstract
Background: Objective of the present cross-sectional study was to investigate the impact of caffeine consumption on fatty liver and serum alanine aminotransferase (ALT) concentrations in a random population sample.
Methods: All subjects (n = 1452; 789 women, 663 men; average age 42.3 ± 12.8 years) underwent ultrasonographic examination of the liver and completed a standardized questionnaire regarding personal and lifestyle data, in particular relating to coffee consumption and past medical history. In addition, anthropometric data were documented and laboratory examinations performed. Statistical interpretation of the data was performed descriptively and by means of bivariate and multivariate analysis.
Results: Data of the present study demonstrated a significant association between hepatic steatosis male gender (p < 0.0001), advanced age (p < 0.0001) and elevated body-mass index (BMI; p < 0.0001). No association between caffeine consumption and fatty liver was identified. An association between caffeine consumption and elevated serum ALT concentrations was not identified.
Conclusions: The findings of the present study provide no evidence for an association between caffeine consumption and either the prevalence of hepatic steatosis or serum ALT concentrations.
Figures
Similar articles
-
Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.Nutrients. 2018 Jan 15;10(1):89. doi: 10.3390/nu10010089. Nutrients. 2018. PMID: 29342916 Free PMC article.
-
Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis.Therap Adv Gastroenterol. 2016 Jan;9(1):113-20. doi: 10.1177/1756283X15593700. Therap Adv Gastroenterol. 2016. PMID: 26770272 Free PMC article. Review.
-
Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.BMC Gastroenterol. 2015 Jul 28;15:88. doi: 10.1186/s12876-015-0321-3. BMC Gastroenterol. 2015. PMID: 26215323 Free PMC article.
-
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.Hepatology. 2012 Feb;55(2):429-36. doi: 10.1002/hep.24731. Epub 2011 Dec 22. Hepatology. 2012. PMID: 21987293
-
Coffee: good, bad, or just fun? A critical review of coffee's effects on liver enzymes.Nutr Rev. 2006 Jan;64(1):43-6. doi: 10.1111/j.1753-4887.2006.tb00172.x. Nutr Rev. 2006. PMID: 16491669 Review.
Cited by
-
Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates.Int J Mol Sci. 2022 Mar 2;23(5):2764. doi: 10.3390/ijms23052764. Int J Mol Sci. 2022. PMID: 35269912 Free PMC article. Review.
-
Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596. eCollection 2021. Front Pharmacol. 2021. PMID: 34966282 Free PMC article. Review.
-
Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.Nutrients. 2021 Aug 30;13(9):3042. doi: 10.3390/nu13093042. Nutrients. 2021. PMID: 34578919 Free PMC article.
-
Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis.Ann Gastroenterol. 2021;34(3):404-414. doi: 10.20524/aog.2021.0604. Epub 2021 Feb 26. Ann Gastroenterol. 2021. PMID: 33948067 Free PMC article.
-
Lifestyle modification in NAFLD/NASH: Facts and figures.JHEP Rep. 2019 Nov 5;1(6):468-479. doi: 10.1016/j.jhepr.2019.10.008. eCollection 2019 Dec. JHEP Rep. 2019. PMID: 32039399 Free PMC article. Review.
References
-
- Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, Lu Y, Coakley FV, Callen PW. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging. 2009;33:110–115. doi: 10.1016/j.clinimag.2008.06.036. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous